Investing in Therapies that Accelerate Health Equity

1

• Syridex Bio is an impact-driven, life
  sciences-focused firm investing in therapies that
  accelerate global health equity by addressing the
  needs of underserved communities. Syridex Bio was
  founded on the belief that everyone deserves the
  opportunity to live a healthy life. For too long,
  deep inequities have persisted across our
  pharmaceutical, biotechnology, and medical
  systems. Despite increased public attention on
  the problem in recent years, progress remains far
  too slow. At Syridex Bio, we are addressing this
  gap in the market by strategically investing in
  therapies that treat diseases disproportionately
  affecting minoritized communities. By financing
  the development of drugs and treatments
  addressing the worlds greatest health
  disparities, we are convinced that we can
  accelerate health equity globally and achieve
  strong financial returns for our investors.

2
TeamMeet the leaders guiding our work
3
ApproachApproachExplore our investment
philosophy and strategy
4
About Us

• Syridex Bio was founded on the belief that
  everyone deserves the opportunity to live a
  healthy life. For too long, deep inequities have
  persisted across our pharmaceutical,
  biotechnology, and medical systems. Despite
  increased public attention on the problem in
  recent years, progress remains far too slow. 
• At Syridex Bio, we are addressing this gap in the
  market by strategically investing in therapies
  that treat diseases disproportionately affecting
  underserved communities. By financing the
  development of drugs and treatments addressing
  the worlds greatest health disparities, we are
  convinced that we can accelerate health equity
  globally and achieve strong financial returns for
  our investors.

5
Founding Investment Team
Squire ServanceREAD BIO
6
Advisory Board
Anindya Roychowdhury READ BIO
Owen May READ BIO
Veleka Peeples-Dyer READ BIO
Kamil Ali-Jackson READ BIO
Kelvin A. Baggett, MD READ BIO
7
Investment Approach

Investment Focus We draw on our deep
relationships across the global pharmaceutical
and biotech industries to source innovative,
best-in-class clinical stage or near-clinical
stage therapies for diseases that
disproportionately affect underserved
communities. Then, we invest in development to
bring to market novel drugs and treatments that
might otherwise go undeveloped.  Investment
Strategy We invest along two primary strategies
venture creation and private equity. Venture
Creation Building sustainable companies around
innovative products we acquire from life sciences
companies and institutions Private Equity
Privatizing and creating value for undervalued
public pharmaceutical and biotechnology
companies Investment Team Our team is focused on
accelerating health equity and eliminating health
disparities around the world. MEET OUR TEAM
8
Contact Us info_at_syridexbio.com 300 Carnegie
Center, Suite 150, Princeton, NJ 08540